Smart Moves at Year-End
Patient Advocacy Strategies To Set You Up for 2026 and Beyond This time of year, many in pharma and biotech are looking at budgets with an eye toward action: what…
Read More
Blog
: Advocacy
Is Patient Advocacy in Danger of Stalling Out?
This is a challenging time to be a patient or a patient advocate. Extensive cuts at NIH and FDA, a retraction of DEI commitments, major universities losing their funding—all threaten…
Read More
How to Be A Good Advocacy Partner In the Time of COVID-19
With the onset of COVID-19, the world has turned upside down, and our healthcare system is ground zero in the fight to save lives and to support patients and their…
Pharma: Pay Attention to Caregivers
As longtime advocates for caregivers, we were pleased to see the recent post from Eye for Pharma, “Pharma’s new ally: the caregiver,” which outlined the many ways that caregivers could…
Read More
Reflections on the “New Biotechnology and Pharmaceutical Industry Commitment to Patients and the Public”
We read with great interest the Opinion piece in Stat News in which more than 200 corporate leaders—mostly from small and mid-sized companies, as well as some investors—signed on to what…
